In this issue:
Dapagliflozin for HFPEF
Sacubitril/valsartan for advanced HFREF
Prevalence of ATTR-CM in HFPEF
Omecamtiv mecarbil for severe HF
Dapagliflozin in Black vs. White Americans with HFREF
Health status predicts risks of composite clinical outcomes in acute HF
Sacubitril/valsartan adherence and outcomes after hospitalisation for HFREF
Association of early BP decrease and renal function with acute HF prognosis
Association between β-blockers and outcomes in HFPEF
Please login below to download this issue (PDF)